Published in Lab Law Weekly, March 28th, 2008
The Czech Republic Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on the Czech Republics pharmaceuticals and healthcare industry.
The drug market in the Czech Republic is showing promise, although local generics producers may struggle to cash in, in the short-term. BMI forecasts a compound growth rate (CAGR) of 6.84% for 2007-2012. However, recent reforms have targeted older generic drugs, as the authorities attempts to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly